Detalhe da pesquisa
1.
Evidence-based guideline: unexplained infertility.
Hum Reprod
; 38(10): 1881-1890, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37599566
2.
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study.
J Endocrinol Invest
; 42(9): 1089-1097, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30847861
3.
Expectant management may reduce overtreatment in women affected by unexplained infertility confirmed by diagnostic laparoscopy.
Arch Gynecol Obstet
; 295(2): 427-433, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27873054
4.
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study.
J Endocrinol Invest
; 36(8): 636-41, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24105072
5.
On the limited consensus of mountain pine beetle impacts on wildfire.
Landsc Ecol
; 38(9): 2159-2178, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37521154
6.
Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study.
Hum Reprod
; 27(10): 3057-66, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22786777
7.
Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective.
Hum Reprod
; 23(9): 2127-33, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18567896
8.
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome.
J Endocrinol Invest
; 30(11): 948-56, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18250617
9.
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities.
Curr Pharm Des
; 12(8): 1001-12, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16533167
10.
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study.
J Clin Endocrinol Metab
; 89(6): 2817-23, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15181063
11.
Metabolic and endocrine consequences of acute suppression of FFAs by acipimox in polycystic ovary syndrome.
J Clin Endocrinol Metab
; 86(11): 5324-9, 2001 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-11701699
12.
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
J Clin Endocrinol Metab
; 96(5): E821-4, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21307134
13.
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?
Hum Reprod
; 21(12): 3108-15, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17053004
14.
Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: a case report.
J Endocrinol Invest
; 27(1): 70-5, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15053248
15.
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.
Hum Reprod
; 19(3): 534-9, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-14998947
16.
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.
Hum Reprod
; 18(6): 1210-8, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12773448